Javascript must be enabled to continue!
Kinetics Of Plasminogen Activation By Tissue Plasminogen Activator. Role Of Fibrin
View through CrossRef
The activation of human plasminogen (P) by two-chain tissue plasminogen activator (A) was studied in the presence of fibrin films (F) of increasing size and surface density. Initial rates of plasminogen activation (v) were determined as a function both of the plasminogen and fibrin concentration. The activation rate was strongly dependent on the presence of fibrin and plots of 1/v versus 1/ [p] or 1 /[F] yielded straight lines. The kinetic data were in agreement with the following reaction scheme.According to this model tissue plasminogen activator would bind to fibrin with a dissociation constant (KF of 0.2 µM and this complex fixes plasminogen with a Michaelis constant (Kp’) of 0.15 µM (Glu-plasminogen) or 0.02 µM (Lys-plasminogen) to form a ternary complex, converted to plasmin with a catalytic rate constant kcat = 0.05 s-1. This mechanism implies that both plasminogen and tissue plasminogen activator are concentrated on the fibrin surface through formation of a fibrin bridge. Activation of plasminogen in the absence of fibrin occurs with Km = 65 µM (Glu-plasminogen) or Km= 19 µM (Lys-plasminogen) and kcat = 0.05 s-1. Our data suggest that fibrin enhances the activation rate of plasminogen by tissue plasminogen activator by increasing the affinity of plasminogen for fibrin-bound tissue plasminogen activator and not by influencing the catalytic efficiency of the enzµMe. These data also support the hypothesis that fibrinolysis is both triggered by and directed towards fibrin.Generated plasmin was quantitated by measuring the rate of solubilization of 125I-labeled fibrin.
Title: Kinetics Of Plasminogen Activation By Tissue Plasminogen Activator. Role Of Fibrin
Description:
The activation of human plasminogen (P) by two-chain tissue plasminogen activator (A) was studied in the presence of fibrin films (F) of increasing size and surface density.
Initial rates of plasminogen activation (v) were determined as a function both of the plasminogen and fibrin concentration.
The activation rate was strongly dependent on the presence of fibrin and plots of 1/v versus 1/ [p] or 1 /[F] yielded straight lines.
The kinetic data were in agreement with the following reaction scheme.
According to this model tissue plasminogen activator would bind to fibrin with a dissociation constant (KF of 0.
2 µM and this complex fixes plasminogen with a Michaelis constant (Kp’) of 0.
15 µM (Glu-plasminogen) or 0.
02 µM (Lys-plasminogen) to form a ternary complex, converted to plasmin with a catalytic rate constant kcat = 0.
05 s-1.
This mechanism implies that both plasminogen and tissue plasminogen activator are concentrated on the fibrin surface through formation of a fibrin bridge.
Activation of plasminogen in the absence of fibrin occurs with Km = 65 µM (Glu-plasminogen) or Km= 19 µM (Lys-plasminogen) and kcat = 0.
05 s-1.
Our data suggest that fibrin enhances the activation rate of plasminogen by tissue plasminogen activator by increasing the affinity of plasminogen for fibrin-bound tissue plasminogen activator and not by influencing the catalytic efficiency of the enzµMe.
These data also support the hypothesis that fibrinolysis is both triggered by and directed towards fibrin.
Generated plasmin was quantitated by measuring the rate of solubilization of 125I-labeled fibrin.
Related Results
On The Fibrinolytic Properties Of Single-Chain And Two- Chain Human Tissue Plasminogen Activator
On The Fibrinolytic Properties Of Single-Chain And Two- Chain Human Tissue Plasminogen Activator
Tissue plasminogen activator from pig hearts may be isolated as a single-chain or as a two-chain molecule (Wallén et al., 1980). The present report deals with the two molecular for...
Abstract 1645: Characterization of a novel anti-insoluble-fibrin chimeric antibody (AFCA) for cancer stromal target (CAST) therapy and diagnosis.
Abstract 1645: Characterization of a novel anti-insoluble-fibrin chimeric antibody (AFCA) for cancer stromal target (CAST) therapy and diagnosis.
Abstract
Background: A large body of clinicopathological evidence supports the conclusion that abnormal coagulation occurs in a variety of cancers. In the non-malign...
Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface
Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface
A well-characterized in vitro model system composed of thrombin- stimulated gel-filtered human platelets, fibrin-(ogen), plasminogen, and recombinant tissue plasminogen activator (...
Efeito do ácido tranexâmico associado à cola de fibrina sobre o reparo ósseo: estudo histológico em ratos
Efeito do ácido tranexâmico associado à cola de fibrina sobre o reparo ósseo: estudo histológico em ratos
O processo de reparação óssea é controlado por mecanismos moleculares complexos que envolvem fatores sistêmicos e locais. Os adesivos fibrínicos, também conhecidos como selantes de...
Physiology of Plasminogen: With Special Reference to Activation and Degradation
Physiology of Plasminogen: With Special Reference to Activation and Degradation
Plasminogen is said to be synthesized in many organs, but the major source of its production is considered to be the liver. The production of plasminogen is observed in fetal life,...
Binding of human plasminogen to Borrelia burgdorferi
Binding of human plasminogen to Borrelia burgdorferi
We studied the binding of plasminogen to Borrelia burgdorferi, a spirochete which causes Lyme disease and produces no endogenous proteases which digest extracellular matrix protein...
Molecular Biological Aspects of Fibrinolysis
Molecular Biological Aspects of Fibrinolysis
The fibrinolytic enzyme system plays a role in the removal of fibrin from the blood vessels or urinary tract, and also in tissue repair (angiogenesis), cell transformation, macroph...

